10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.62
-0.52 (-2.25%)
Mar 3, 2026, 4:00 PM EST - Market closed
10x Genomics Analyst Ratings
Total Analysts
14
Consensus Rating
Hold
Price Target
$17.18
Upside
-24.05%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | +10.52% | Mar 2, 2026 |
| UBS | UBS | Hold Maintains $14 → $20 | Hold | Maintains | $14 → $20 | -11.58% | Feb 20, 2026 |
| Stifel | Stifel | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | -11.58% | Feb 13, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | -16.00% | Feb 13, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | -11.58% | Jan 27, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -2.74% | Jan 16, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $15 → $20 | Hold | Maintains | $15 → $20 | -11.58% | Jan 7, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $15 → $18 | Hold | Maintains | $15 → $18 | -20.42% | Jan 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | -11.58% | Dec 22, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | -2.74% | Dec 15, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $18 | Strong Buy → Hold | Downgrades | $18 | -20.42% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $17 → $20 | Buy → Hold | Downgrades | $17 → $20 | -11.58% | Dec 2, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | -16.00% | Nov 11, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $19 | Strong Buy | Maintains | $16 → $19 | -16.00% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | -33.69% | Nov 7, 2025 |
| UBS | UBS | Hold Maintains $13 → $14 | Hold | Maintains | $13 → $14 | -38.11% | Nov 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.